StockData
CANFNYSEPharmaceutical PreparationsFiscal year ends December 31

Can-Fite BioPharma Ltd.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026
$1.89+0.13 (+7.39%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Can-Fite BioPharma has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Can-Fite BioPharma filed with the SEC